BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22029600)

  • 1. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH; Lee YH; Lee SH; Lee SR; Huh JW; Kim SU; Chang KT
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-primed CD11b
    Niu S; Paluszynski J; Bian Z; Shi L; Kidder K; Liu Y
    Sci Rep; 2018 Mar; 8(1):3994. PubMed ID: 29507316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.
    Sheoran AS; Dmitriev IP; Kashentseva EA; Cohen O; Mukherjee J; Debatis M; Shearer J; Tremblay JM; Beamer G; Curiel DT; Shoemaker CB; Tzipori S
    Infect Immun; 2015 Jan; 83(1):286-91. PubMed ID: 25368111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome.
    Pysher TJ; Siegler RL; Tesh VL; Taylor FB
    Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.
    Ludwig K; Sarkim V; Bitzan M; Karmali MA; Bobrowski C; Ruder H; Laufs R; Sobottka I; Petric M; Karch H; Müller-Wiefel DE
    J Clin Microbiol; 2002 May; 40(5):1773-82. PubMed ID: 11980959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice.
    Zoja C; Locatelli M; Pagani C; Corna D; Zanchi C; Isermann B; Remuzzi G; Conway EM; Noris M
    J Immunol; 2012 Oct; 189(7):3661-8. PubMed ID: 22942429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006.
    Gould LH; Demma L; Jones TF; Hurd S; Vugia DJ; Smith K; Shiferaw B; Segler S; Palmer A; Zansky S; Griffin PM
    Clin Infect Dis; 2009 Nov; 49(10):1480-5. PubMed ID: 19827953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
    Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
    J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
    Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
    Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS).
    Mejias MP; Fernandez-Brando RJ; Ramos MV; Abrey-Recalde MJ; Zotta E; Meiss R; Palermo MS
    Curr Pharm Des; 2016; 22(34):5294-5299. PubMed ID: 27356777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.